Artemisinin is a drug, widely used in malaria treatment. As the binding affinity of artemisinin and its derivatives dihydroartemisinin and artesunate to blood serum proteins might influence the effectiveness of the drug, binding of artemisinin and derivatives to serum albumin was studied under near physiological conditions. Binding kinetics indicate a simple, single-step association process for all artemisinin derivatives. The determined changes in enthalpy and entropy upon drug binding clearly indicate that hydrophobic forces are most important for artemisinin and dihydroartemisinin binding, whereas binding of artesunate is governed by both hydrophilic and hydrophobic forces. Key residues, which are most likely involved in binding of the respective compounds, were identified in subsequent protein/drug docking studies. The obtained results not only explain differences in between artemisinin and derivatives but generally illustrate how slight modifications in a drug can significantly affect principles underlying drug binding to target proteins.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phymed.2013.04.003DOI Listing

Publication Analysis

Top Keywords

artemisinin derivatives
16
drug binding
12
artemisinin dihydroartemisinin
8
dihydroartemisinin artesunate
8
serum albumin
8
binding
8
hydrophobic forces
8
artemisinin
7
drug
5
differential interactions
4

Similar Publications

[Research progress on artemisinin and its derivatives in treatment of orthopedics-related diseases].

Zhongguo Zhong Yao Za Zhi

September 2024

Tianjin Hospital, Tianjin University (Tianjin Hospital) Tianjin 300211, China Tianjin Institute of Orthopedics Tianjin 300050, China Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering Tianjin 300050, China.

As research into the mechanisms of orthopedic diseases continues to deepen, the shortcomings of traditional single-target the-rapies are becoming increasingly apparent. Consequently, the search for multi-target drugs has become the mainstream research direction for orthopedics-related diseases. Artemisinin, a sesquiterpene lactone compound extracted from Artemisia annua, has led to the gradual synthesis of various derivatives such as dihydroartemisinin, artesunate, artemether, and arteether.

View Article and Find Full Text PDF
Article Synopsis
  • - COVID-19 has caused around 7 million deaths from 2019 to 2022, emphasizing the urgent need for research into its mechanisms and treatment options.
  • - One major aspect of severe COVID-19 is the abnormal immune response, particularly the damaging cytokine storms, with recent studies highlighting the important role of the signaling molecule TGF-β in this process.
  • - The review discusses potential treatments that target TGF-β signaling, including specific drugs and ongoing clinical trials, aiming to improve outcomes for COVID-19 patients by reducing disease severity.
View Article and Find Full Text PDF

The increased resistance of Plasmodium falciparum to artemisinin and its partner drugs poses a serious challenge to global malaria control and elimination programs. This study aimed to investigate the therapeutic potential of Mesua ferrea Linn., a medicinal plant, as a source for novel antimalarial compounds.

View Article and Find Full Text PDF

Antimalarial Drug Artemotil Promotes Induction of Type 1 Regulatory T Cells.

Inflammation

November 2024

Centre for Immuno-Biology and Immunotherapy, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India.

Artemisinin and its derivatives, used as front-line anti-malarial drugs, exhibit anti-inflammatory properties. They were found to suppress the generation and function of Th1 and Th17 cells while promoting the generation of Foxp3 + regulatory T cells (Tregs). However, the specific role of Artemotil (β-arteether) in modulating the generation and functions of CD4 + T cells, particularly Type 1 regulatory T cells (Tr1), remains to be explored.

View Article and Find Full Text PDF
Article Synopsis
  • * The primary current treatment is artemisinin-based combination therapies (ACTs), but rising resistance to these drugs, particularly in Southeast Asia, threatens advancements made in battling the disease.
  • * The review explores various antimalarial drugs, challenges of drug resistance, and the importance of new therapies and vaccines in the ongoing fight against malaria and aims for its eventual eradication.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!